Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Buchanan

Showing results (51-60 of 87) with videos related to

Pageof 9
Sort By:
British Journal of Cancer|June 2, 2025
Preferences for multi-cancer tests (MCTs) in primary care: discrete choice experiments of general practitioners and the general public in EnglandJohn Buckell, Nomalanga Madyiwa, Gail Hayward, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 28, 2026
Content validity, face validity and comprehensiveness of generic quality-of-life measures in adults and children with rare genetic conditions and their carers: a think aloud qualitative studyMackenzie Bourke, Xuemin Zhu, Tiffany Boughtwood, et al.
Nature Medicine|June 19, 2024
Exploring the benefits, harms and costs of genomic newborn screening for rare diseasesEmma L Baple, Richard H Scott, Siddharth Banka, et al.
Genomic Medicine|October 17, 2008
Diagnosing idiopathic learning disability: a cost-effectiveness analysis of microarray technology in the National Health Service of the United KingdomSarah Wordsworth, James Buchanan, Regina Regan, et al.
Applied Health Economics and Health Policy|April 4, 2022
Financing and Reimbursement Models for Personalised Medicine: A Systematic Review to Identify Current Models and Future OptionsRositsa Koleva-Kolarova, James Buchanan, Heleen Vellekoop, et al.
Communications Medicine|May 25, 2024
Overcoming challenges in the economic evaluation of interventions to optimise antibiotic useLaurence S J Roope, Liz Morrell, James Buchanan, et al.
Applied Health Economics and Health Policy|January 20, 2025
Approaches to Incorporation of Preferences into Health Economic Models of Genomic Medicine: A Critical Interpretive Synthesis and Conceptual FrameworkHadley Stevens Smith, Dean A Regier, Ilias Goranitis, et al.
JAMA Network Open|July 10, 2024
Health Care Costs After Genome-Wide Sequencing for Children With Rare Diseases in England and CanadaDeirdre Weymann, John Buckell, Patrick Fahr, et al.
Applied Health Economics and Health Policy|March 8, 2021
Preferences for Medical Consultations from Online Providers: Evidence from a Discrete Choice Experiment in the United KingdomJames Buchanan, Laurence S J Roope, Liz Morrell, et al.
Springerplus|July 22, 2016
Safety and tolerability of etirinotecan pegol in advanced breast cancer: analysis of the randomized, phase 3 BEACON trialJavier Cortés, Hope S Rugo, Chris Twelves, et al.
Pageof 9

Showing results (51-60 of 87) with videos related to

Sort By:
Pageof 9
British Journal of Cancer|June 2, 2025
Preferences for multi-cancer tests (MCTs) in primary care: discrete choice experiments of general practitioners and the general public in EnglandJohn Buckell, Nomalanga Madyiwa, Gail Hayward, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 28, 2026
Content validity, face validity and comprehensiveness of generic quality-of-life measures in adults and children with rare genetic conditions and their carers: a think aloud qualitative studyMackenzie Bourke, Xuemin Zhu, Tiffany Boughtwood, et al.
Nature Medicine|June 19, 2024
Exploring the benefits, harms and costs of genomic newborn screening for rare diseasesEmma L Baple, Richard H Scott, Siddharth Banka, et al.
Genomic Medicine|October 17, 2008
Diagnosing idiopathic learning disability: a cost-effectiveness analysis of microarray technology in the National Health Service of the United KingdomSarah Wordsworth, James Buchanan, Regina Regan, et al.
Applied Health Economics and Health Policy|April 4, 2022
Financing and Reimbursement Models for Personalised Medicine: A Systematic Review to Identify Current Models and Future OptionsRositsa Koleva-Kolarova, James Buchanan, Heleen Vellekoop, et al.
Communications Medicine|May 25, 2024
Overcoming challenges in the economic evaluation of interventions to optimise antibiotic useLaurence S J Roope, Liz Morrell, James Buchanan, et al.
Applied Health Economics and Health Policy|January 20, 2025
Approaches to Incorporation of Preferences into Health Economic Models of Genomic Medicine: A Critical Interpretive Synthesis and Conceptual FrameworkHadley Stevens Smith, Dean A Regier, Ilias Goranitis, et al.
JAMA Network Open|July 10, 2024
Health Care Costs After Genome-Wide Sequencing for Children With Rare Diseases in England and CanadaDeirdre Weymann, John Buckell, Patrick Fahr, et al.
Applied Health Economics and Health Policy|March 8, 2021
Preferences for Medical Consultations from Online Providers: Evidence from a Discrete Choice Experiment in the United KingdomJames Buchanan, Laurence S J Roope, Liz Morrell, et al.
Springerplus|July 22, 2016
Safety and tolerability of etirinotecan pegol in advanced breast cancer: analysis of the randomized, phase 3 BEACON trialJavier Cortés, Hope S Rugo, Chris Twelves, et al.
Pageof 9